COLUMBUS,
Ohio – Diabetes researchers and clinicians from around the world will be at
Ohio State’s Wexner Medical Center next month to discuss the latest in diabetes
research and treatment at the second Global Diabetes Summit.
The
conference will be held Nov. 14-16 at the Ohio Union on The Ohio State
University campus, where international diabetes experts will present the latest
diabetes research and formulate an interdisciplinary road map for prevention,
detection, management and treatment of Type 1, Type 2 and gestational
diabetes.
The
summit, “New Horizons in Diabetes: Genetic to Personalized Health Care,” is
expected to attract more than 800 health care professionals. A variety of diabetes
physicians, researchers and advocates will present research findings on
diabetes technology, cellular and tissue therapies, islet cell therapy,
pharmacology, pregnancy and cardiovascular disease and other relevant topics. Notable speakers include:
·
Ann Albright, PhD, RD – Director of
Diabetes Translation, Centers for Disease Control and Prevention, will discuss
the research behind the U.S. National Diabetes Prevention Program.
·
Jean–Claude Mbanya, MD, PhD, FRCP – President,
International Diabetes Federation, will focus on the global pandemic of obesity
and diabetes in adults, include epidemiological solutions and challenges, and
the global economic impact of diabetes.
·
Vivian Fonseca, MD,
FRCP
– President, American Diabetes Association, will discuss future oral
anti-diabetic medications.
·
Griffin Rodgers, MD,
MBA, MACP
– Director, The National Institute of Diabetes and Digestive and Kidney Diseases,
will present on genomics and diabetes.
On Nov. 17, the final day of the summit, the
Community Day– the largest of its kind in the Midwest – will be held to give
community members the opportunity to ask one-on-one questions in self-care
sessions about diabetes management and concerns. Panels featuring experts and
hands-on workshops will bridge the educational gap for patients and their
family members most affected by diabetes. Celebrity
guests Dominique Wilkins, NBA Hall of Fame legend and vice president of
basketball for the Atlanta Hawks; and Oscar Joyner, president and chief
operating officer of REACH Media, Inc., will speak about personal battles with
diabetes and management of their disease. The event, which is free
and open to the public, will be held at Franklin County Veterans Memorial,
300 W. Broad St., but
registration
is required. To register, go to: go.osu.edu/GDScommunity.
The issues, discoveries and strategies
discussed at the summit will impact the work of researchers, providers,
policymakers, stakeholders and health care agencies in the United States and
around the world.
The Global Diabetes Summit is hosted by Ohio
State Wexner Medical Center’s Diabetes Research Center which, under the
direction of Dr. Kwame Osei, provides innovative research, patient
care and education programs focused on improving diabetes control, prevention
and providing a cure for those with diabetes. The interdisciplinary center
conducts clinical trials and performs basic research associated with islet
cell, pancreas and kidney transplantation.
Diabetes
and its complications are major causes of early death in most countries. In 2011, approximately 4.6
million people ages 20-79 died from diabetes, accounting for 8.2 percent of
global all-cause mortality of people in this age group. Additionally,
diabetes adds a significant cost to health systems, costing the United States
$174 billion annually, according to the American Diabetes Association.
For more information about the Summit, go to: diabetesresearch.osu.edu.
# # #
Contact: Gina Bericchia, Wexner Medical Center
Public Affairs & Media Relations, 614-293-3737, Gina.Berichia@osumc.edu
